CD8A and tuberculosis: An adenovirus-vectored tuberculosis vaccine (AdAg85A) was used as a model replication-defective viral vector vaccine and this vaccine, when delivered via respiratory mucosal and parenteral intramuscular routes, induced Ag-specific CD8 T cell responses in the lung21, 28.